BOSTON, Sept. 14, 2021 /PRNewswire/ — Boston Children’s Hospital today announced a $20 million gift from the Benderson Family Foundation to fuel the next generation of discoveries in the treatment of pediatric heart disease. In recognition of this gift, the hospital is honored to rename its combined cardiovascular programs the Benderson Family Heart Center […]
Financial
HeartFlow Holding, Inc. Provides Selected Preliminary Second Quarter 2021 Financial Results and Updated Guidance for Full Year 2021
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow Holding, Inc. (“HeartFlow” or the “Company”), the leader in revolutionizing precision heart care, today announced selected preliminary financial results for the period ended June 30, 2021 and provided updated guidance for the year ending December 31, 2021. Financial Highlights Revenue for the second quarter of 2021 was […]
Vibrato Medical Closes $4M Series A Funding Round and Receives $1.5M NIH Grant
Funds will support the company’s mission of advancing noninvasive treatment options for people with reduced tissue perfusion IRVINE, Calif.–(BUSINESS WIRE)–Vibrato Medical, an innovator in the treatment of peripheral arterial disease (PAD), announced today that it has closed a $4M Series A funding round led by the Horowitz Group, a multi-asset […]
CardioFocus Announces Agreement to Acquire Intellectual Property
MARLBOROUGH, Mass., September 14, 2021 – CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has entered into an agreement with IsoLase Ltd. to acquire IsoLase’s patent portfolio. The acquisition agreement includes US patents 8,992,514 and 10,517,669 and EU patent […]
iRhythm® Technologies Names Quentin Blackford President and Chief Executive Officer
Accomplished MedTech Leader with Proven Track Record of Strategic, Operational and Financial Execution with High Growth Companies SAN FRANCISCO, Sept. 13, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Quentin Blackford has […]
ZOLL Medical Corporation Signs Definitive Agreement to Acquire Itamar Medical
Acquiring provider of home sleep apnea diagnosis solutions will allow ZOLL to better serve undiagnosed and untreated cardiac patients CHELMSFORD, Mass. & CAESAREA, Israel–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Itamar™ Medical Ltd. (Nasdaq and TASE: ITMR), a medical device and […]
MedTech company STENTiT announces the appointment of a Medical Advisory Board, chaired by Prof. Patrick Serruys and complemented by Prof. Marc van Sambeek and Prof. Yoshinobu Onuma
EINDHOVEN, Netherlands, Sept. 13, 2021 /PRNewswire/ — STENTiT, a medical device company bringing a novel class of regenerative endovascular implants for treatment of cardiovascular diseases, today announced the appointment of its Medical Advisory Board, chaired by Prof. Patrick Serruys and complemented by Prof. Marc van Sambeek and Prof. Yoshinobu Onuma. Bart Sanders, CEO of STENTiT, said: “We are excited to receive […]
Xenter, Inc. Appoints Mark Turco, MD as President of Xenter’s Medical Technologies Business Unit
Xenter Medical Technologies Expands, Focuses Initially on the Development of a New Wireless Vascular Imaging and Physiology Platform, Prepares New Global Platform to Collect and Store Physical Intelligence SALT LAKE CITY–(BUSINESS WIRE)–Following the formation of the Xenter Therapeutics business unit, Xenter, Inc. (XenterMD.com), the first purpose-built medical device-data-drug technologies company, today announced […]
Nectero Medical Completes $19.5 Million Series C Financing
Proceeds from new investors will fund in vivo and clinical development of innovative platform for aneurysmal disease, including Abdominal Aortic Aneurysms (AAA) TEMPE, Ariz.–(BUSINESS WIRE)–Nectero Medical Inc. today announced the closing of its $19.5 million Series C financing round, led by new investor Boston Scientific Corporation, a leading global medical device manufacturer. Proceeds […]
Venturis Therapeutics, Inc. Announces Strategic Alliance with Prevail InfoWorks, Inc. and Prevail Partners, LLC
DALLAS, Sept. 9, 2021 /PRNewswire/ — Venturis Therapeutics, Inc. (“VT” or the “Company”) announced it has entered into a strategic alliance with Prevail InfoWorks, Inc. (“InfoWorks”), with the intent to deploy InfoWorks’ cutting-edge capabilities and technology to take a leadership position in the management and the advancement of the VT Coronary Artery […]



